Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Crohn’s disease

Johnson & Johnson
Regional

FDA Approves TREMFYA® for Crohn’s Disease, Offering New Treatment Options

March 22, 2025March 21, 2025 - by Timothy Alexander

HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® (guselkumab) for the treatment of adults with moderately to severely …

FDA Approves TREMFYA® for Crohn’s Disease, Offering New Treatment Options Read More

Food and Drug Administration
National / Pediatrics

FDA Issues New Guidance for Pediatric Inflammatory Bowel Disease Drug Development

July 25, 2024July 24, 2024 - by Maryann Pugh

WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently issued a draft guidance aimed at improving the clinical development of drugs to treat pediatric patients with inflammatory bowel disease …

FDA Issues New Guidance for Pediatric Inflammatory Bowel Disease Drug Development Read More

Trending News

  • VA Expands Burial Benefits for Veterans Receiving Hospice Care at Home

  • Fugitive Husband Accused of Brutal Assault Captured After Weeks on the Run

  • Teen Shot in Wilmington Overnight, Police Urge Witnesses to Come Forward

  • Man Shot in Wilmington Late-Night Attack — Police Urge Witnesses to Come Forward

  • West Chester Event to Premiere Powerful Youth Documentary and Celebrate Restorative Justice

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

US Department of Veterans Affairs

VA Expands Burial Benefits for Veterans Receiving Hospice Care at Home

July 13, 2025July 13, 2025

Michael Antonio McRae

Fugitive Husband Accused of Brutal Assault Captured After Weeks on the Run

July 13, 2025July 13, 2025

Police News

Teen Shot in Wilmington Overnight, Police Urge Witnesses to Come Forward

July 13, 2025July 13, 2025

Copyright © 2025 MyChesCo.